Pediatric non alcoholic fatty liver disease: Old and new concepts on development, progression, metabolic insight and potential treatment targets

Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard

9 p | 15 | 1

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: Design and rationale of randomized controlled trial

11 p | 25 | 1

Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes

6 p | 12 | 1

Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease

13 p | 19 | 1

A clinically relevant method to screen for hepatic steatosis in overweight adolescents: A cross sectional study

8 p | 15 | 0

Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: Analysis from the German/Austrian/Swiss obesity registry APV

10 p | 17 | 0